Show simple item record

CLINICAL BENEFIT OF CABAZITAXEL PLUS PREDNISONE IN THE TROPIC TRIAL IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) WHO PROGRESSED AFTER DOCETAXEL-BASED TREATMENT

dc.contributor.authorSartor, A. O.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorGravis, G.
dc.contributor.authorShen, L.
dc.contributor.authorde Bono, J. S.
dc.contributor.authorTombal, B.
dc.contributor.authorOudard, S.
dc.contributor.authorHansen, S.
dc.contributor.authorKocak, I
dc.date.accessioned2021-03-05T21:04:09Z
dc.date.available2021-03-05T21:04:09Z
dc.date.issued2011
dc.identifier.citationTombal B., Oudard S., Ozguroglu M., Hansen S., Kocak I., Gravis G., Sartor A. O. , Shen L., de Bono J. S. , "CLINICAL BENEFIT OF CABAZITAXEL PLUS PREDNISONE IN THE TROPIC TRIAL IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) WHO PROGRESSED AFTER DOCETAXEL-BASED TREATMENT", EUROPEAN UROLOGY SUPPLEMENTS, cilt.10, ss.335-336, 2011
dc.identifier.issn1569-9056
dc.identifier.othervv_1032021
dc.identifier.otherav_d730c37e-375e-4665-9abe-04ea9eb766f2
dc.identifier.urihttp://hdl.handle.net/20.500.12627/141988
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectNefroloji
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.titleCLINICAL BENEFIT OF CABAZITAXEL PLUS PREDNISONE IN THE TROPIC TRIAL IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) WHO PROGRESSED AFTER DOCETAXEL-BASED TREATMENT
dc.typeMakale
dc.relation.journalEUROPEAN UROLOGY SUPPLEMENTS
dc.contributor.departmentUniversite Catholique Louvain , ,
dc.identifier.volume10
dc.identifier.issue2
dc.identifier.startpage335
dc.identifier.endpage336
dc.contributor.firstauthorID199801


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record